Subjects receiving varenicline were more likely than those receiving placebo to achieve abstinence ( 10.5 versus 0 % , P = 0.03 ; effect size 10.5 % , 95 % confidence interval ( CI ) = 4.4-19 .3 % ) and to reduce smoking ( median five versus two cigarettes/day , P < 0.001 ) at 12 weeks .